Maurine D. Miner

Cape Town HVTN Immunology Laboratory / Hutchinson Centre Research Institute of South Africa

Also affiliated with Fred Hutch Cancer Center, University of KwaZulu-Natal

Immunology and MicrobiologyMedicineBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 20 papers. Top paper: “A phase 1b randomized study of the safety and immunological responses to vaccination with H4:IC31, H56:IC31, and BCG revaccination in Mycobacterium tuberculosis-uninfected adolescents in Cape Town, South Africa”.

A phase 1b randomized study of the safety and immunological responses to vaccination with H4:IC31, H56:IC31, and BCG revaccination in Mycobacterium tuberculosis-uninfected adolescents in Cape Town, South Africa

EClinicalMedicine(2020)10.1016/j.eclinm.2020.100313

N/A

2.3DataRank · unranked

75 citations

One Dintwe, Andrew Fioré-Gartland, Keren Middelkoop, Julia Hütter, Anthony Williams +16 more

Phase 1 Human Immunodeficiency Virus (HIV) Vaccine Trial to Evaluate the Safety and Immunogenicity of HIV Subtype C DNA and MF59-Adjuvanted Subtype C Envelope Protein

Clinical Infectious Diseases(2020)10.1093/cid/ciz1239

N/A

1.2DataRank · unranked

35 citations

Craig Innes, Sarita Naidoo, Philipp Mann, Julia Hütter, Gita Ramjee +69 more

Safety, tolerability, pharmacokinetics, and immunological activity of dual-combinations and triple-combinations of anti-HIV monoclonal antibodies PGT121, PGDM1400, 10-1074, and VRC07-523LS administered intravenously to HIV-uninfected adults: a phase 1 randomised trial

The Lancet HIV(2023)10.1016/s2352-3018(23)00140-6

N/A

1.1DataRank · unranked

33 citations

Sharon Mannheimer, Carmen A. Paez, Chenchen Yu, Theresa Gamble, Deborah Theodore +22 more

Neutralizing antibody responses over time in demographically and clinically diverse individuals recovered from SARS-CoV-2 infection in the United States and Peru: A cohort study

PLoS Medicine(2021)10.1371/journal.pmed.1003868

N/A

1.1DataRank · unranked

25 citations

Shuying Sue Li, Shannon Grant, Stephen R. Walsh, Ian Frank, Martin Casapia-Morales +11 more

Post-COVID symptom profiles and duration in a global convalescent COVID-19 observational cohort: Correlations with demographics, medical history, acute COVID-19 severity and global region

Journal of Global Health(2023)10.7189/jogh.13.06020

N/A

0.671DataRank · unranked

19 citations

Jorge A. Gallardo-Cartagena, Deborah Theodore, Portia Hunidzarira, Juan José Montenegro-Idrogo, Jiani Hu +17 more

Safety and immunogenicity of a subtype C ALVAC-HIV (vCP2438) vaccine prime plus bivalent subtype C gp120 vaccine boost adjuvanted with MF59 or alum in healthy adults without HIV (HVTN 107): A phase 1/2a randomized trial

PLoS Medicine(2024)10.1371/journal.pmed.1004360

N/A

0.439DataRank · unranked

9 citations

Erica Andersen‐Nissen, Nicole Grunenberg, One Dintwe, Faatima Laher Omar, Jia Jin Kee +29 more

Cellular and humoral responses to an HIV DNA prime by electroporation boosted with recombinant vesicular stomatitis virus expressing HIV subtype C Env in a randomized controlled clinical trial

Vaccine(2023)10.1016/j.vaccine.2023.03.015

N/A

0.405DataRank · unranked

8 citations

Benigno Rodríguez, Shuying Sue Li, Mary Allen, Ian Frank, Erika Rudnicki +17 more

Safety, tolerability, pharmacokinetics, and neutralisation activities of the anti-HIV-1 monoclonal antibody PGT121.414.LS administered alone and in combination with VRC07-523LS in adults without HIV in the USA (HVTN 136/HPTN 092): a first-in-human, open-label, randomised controlled phase 1 trial

The Lancet HIV(2024)10.1016/s2352-3018(24)00247-9

N/A

0.381DataRank · unranked

11 citations

Christopher B. Hurt, Kathryn E. Stephenson, Yunda Huang, Carmen A. Paez, Chenchen Yu +95 more

Safety, pharmacokinetics, and neutralisation activity of PGDM1400LS, a V2 specific HIV-1 broadly neutralising antibody, infused intravenously or subcutaneously in people without HIV-1 in the USA (HVTN 140/HPTN 101 part A): a first-in-human, phase 1 randomised trial

The Lancet HIV(2025)10.1016/s2352-3018(25)00012-8

N/A

0.292DataRank · unranked

6 citations

Carmen A. Paez, Chenchen Yu, Shelly Karuna, Theresa Gamble, Maurine D. Miner +32 more

Hybrid versus vaccine immunity of mRNA-1273 among people living with HIV in East and Southern Africa: a prospective cohort analysis from the multicentre CoVPN 3008 (Ubuntu) study

EClinicalMedicine(2025)10.1016/j.eclinm.2024.103054

N/A

0.269DataRank · unranked

5 citations

Asa Tapley, Aaron Hudson, Sufia Dadabhai, Bo Zhang, Nyaradzo Mgodi +93 more

Safety and immunogenicity after a 30-month boost of a subtype C ALVAC-HIV (vCP2438) vaccine prime plus bivalent subtype C gp120/MF59 vaccine boost (HVTN 100): A phase 1–2 randomized double-blind placebo-controlled trial

PLOS Global Public Health(2024)10.1371/journal.pgph.0003319

N/A

0.108DataRank · unranked

1 citations

Fatima Laher, Linda‐Gail Bekker, Kelly E. Seaton, Mary Allen, Stephen De Rosa +27 more

A Phase 2b Study to Evaluate the Safety and Efficacy of VRC01 Broadly Neutralizing Monoclonal Antibody in Reducing Acquisition of HIV-1 Infection in Women in Sub-Saharan Africa: Baseline Findings

UNC Libraries(2023)10.17615/42e2-fv64

N/A

0DataRank · unranked

0 citations

Simbarashe Takuva, Nyaradzo Mgodi, Srilatha Edupuganti, Gomez Lorenzo, M.M., Maurine D. Miner +24 more

Local Power: The Role of Tissue-Resident Immunity in Human Genital Herpes Simplex Virus Reactivation

Viruses(2024)10.3390/v16071019

N/A

0DataRank · unranked

3 citations

Maurine D. Miner, Jia Zhu

High Asymptomatic Carriage With the Omicron Variant in South Africa

Clinical Infectious Diseases(2022)10.1093/cid/ciac237

N/A

0DataRank · unranked

81 citations

Asa Tapley, Jessica Andriesen, Ishen Seocharan, Leigh H. Fisher, Lisa Bunts +85 more

Hybrid versus vaccine immunity of mRNA-1273 among people living with HIV in East and Southern Africa: a prospective cohort analysis from the multicentre CoVPN 3008 (Ubuntu) study

UNC Libraries(2025)10.17615/p4hj-9n46

N/A

0DataRank · unranked

0 citations

Jia Jin Kee, Mubiana Inambao, Essack Mitha, Dishiki Kalonji, William Brumskine +76 more

Developing tuberculosis vaccines for people with HIV: consensus statements from an international expert panel

The Lancet HIV(2022)10.1016/s2352-3018(22)00255-7

N/A

0DataRank · unranked

18 citations

Mark Hatherill, Vidya Mave, Glenda Gray, Sharon Nachman, Sarah W. Read +27 more

Accelerating clinical trial development in vaccinology: COVID-19 and beyond

Current Opinion in Immunology(2022)10.1016/j.coi.2022.102206

N/A

0DataRank · unranked

16 citations

Maurine D. Miner, Lawrence Corey

Developing TB Vaccines for People with HIV: A Roadmap: Meeting Consensus Report

Research Square(2022)10.21203/rs.3.rs-1605760/v1

N/A

0DataRank · unranked

1 citations

Mark Hatherill, Vidya Mave, Judith S. Currier, Joseph J. Eron, Glenda Gray +31 more

Meeting Report: South African Medical Research Council Standard of Care in Clinical Research in Low- And Middle-Income Settings Summit, November 2017

(2020)10.14293/111.000/000010.v1

N/A

0DataRank · unranked

0 citations

Linda‐Gail Bekker, Tamara Kredo, Niresh Bhagwandin, Lawrence Corey, Glenda Gray +1 more

Antibody and cellular responses to HIV vaccine regimens with DNA plasmid as compared with ALVAC priming: An analysis of two randomized controlled trials

PLoS Medicine(2020)10.1371/journal.pmed.1003117

N/A

0DataRank · unranked

14 citations

Stephen R. Walsh, Fatima Laher, Lucas Maganga, Michael E. Herce, Sarita Naidoo +28 more